Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Dennis Farrelly"'
Autor:
Carrie Xu, George C. Morton, Vinayak Hosagrahara, Shung Wu, Denis E. Ryono, Jonathan Lippy, Narayanan Hariharan, Kenneth T. Locke, Xiang-Xang Ye, Wei Wang, Liqun Gu, Yi-Xin Li, Fucheng Qu, Peter T. W. Cheng, Sean S. Chen, Kevin O’Malley, Michael Cap, Robert Zahler, Tao Wang, Lori Kunselman, Charles Z. Ding, Cuixia Chu, Rebecca A. Smirk, Neil Flynn, Pratik Devasthale, Hao Zhang, Nathan Morgan, Atsu Apedo, Thomas Harrity, Lisa Zhang, Dennis Farrelly, Arthur M. Doweyko, Zhi Lai, Tim Herpin, Pathanjali Kadiyala
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 25:1196-1205
The design, synthesis and structure–activity relationships of a novel series of 3,4-disubstituted pyrrolidine acid analogs as PPAR ligands is outlined. In both the 1,3- and 1,4-oxybenzyl pyrrolidine acid series, the preferred stereochemistry was sh
Autor:
Lori Kunselman, Narayanan Hariharan, Pathanjali Kadiyala, Kenneth T. Locke, Denis E. Ryono, Thomas Harrity, Wei Wang, Arthur M. Doweyko, Randy Ponticiello, Liqun Gu, Pratik Devasthale, Lisa Zhang, Dennis Farrelly, Rachel Zebo, Michael Cap, Robert Zahler, Jodi K. Muckelbauer, Chiehying Chang, Cuixia Chu, Peter T. W. Cheng, Kevin O’Malley, Nathan Morgan, Litao Zhang, Jonathan Lippy, Vinayak Hosagrahara
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 18:1939-1944
A novel class of azetidinone acid-derived dual PPARalpha/gamma agonists has been synthesized for the treatment of diabetes and dyslipidemia. The preferred stereochemistry in this series for binding and functional agonist activity against both PPARalp
Autor:
Gary J. Grover, Narayanan Hariharan, Wei Wang, Dennis Farrelly, Jeon Yoon T, Fucheng Qu, Rajasree Golla, Zhengping Ma, Lisa Moore, Arthur M. Doweyko, Gamini Chandrasena, Pratik Devasthale, Denis E. Ryono, Lin Cheng, Chen Sean, Peter T. W. Cheng, Wei Sun, Ramakrishna Seethala, Paul G. Sleph, Hao Zhang
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 17:2312-2316
A novel series of potent dual agonists of PPARα and PPARγ, the alkoxybenzylglycines, was identified and explored using a solution-phase library approach. The synthesis and structure–activity relationships of this series of dual PPARα/γ agonists
Autor:
Narayanan Hariharan, Kasim A. Mookhtiar, Liqun Gu, Jimmy Ren, Chen Sean, Ramakrishna Seethala, Michael Cap, Lori Kunselman, Min Zhou, Peter T. W. Cheng, William Fenderson, Chunning Shao, Cuixia Chu, Scott A. Biller, Hao Zhang, Fucheng Qu, Pratik Devasthale, Dennis Farrelly, Jeon Yoon T, Randolph P. Ponticiello, John R. Wetterau, Wei Wang, Wen-Pin Yang, Thomas Harrity, Aaron Tieman, Denis E. Ryono, Richard E. Gregg
Publikováno v:
Diabetes. 55:240-248
Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor (PPAR) activator, was investigated for its antidiabetic properties and its effects on metabolic abnormalities in genetically obese diabetic db/db mice. In db/db mice
Autor:
Aneka Bell, Lisa Zhang, Dennis Farrelly, Denis E. Ryono, Robert Zahler, Jodi K. Muckelbauer, Jonathan Lippy, Chiehying Chang, Cuixia Chu, Thomas Harrity, Carrie Xu, Narayanan Hariharan, Neil Flynn, Vinayak Hosagrahara, Wei Wang, Michael Cap, Lisa Moore, Pathanjali Kadiyala, Peter T. W. Cheng, Hao Zhang, Liqun Gu, Litao Zhang, Kevin O’Malley, Arthur M. Doweyko, Nathan Morgan, Pratik Devasthale, Kenneth T. Locke, Lori Kunselman
Publikováno v:
Bioorganicmedicinal chemistry letters. 19(5)
The design, synthesis and structure–activity relationships of a novel series of N-phenyl-substituted pyrrole, 1,2-pyrazole and 1,2,3-triazole acid analogs as PPAR ligands are outlined. The triazole acid analogs 3f and 4f were identified as potent d
Autor:
Jean M. Whaley, Andrew Peters, Rachel Zebo, Lori Kunselman, Pratik Devasthale, Evan B. Janovitz, Thomas Harrity, Randolph P. Ponticiello, Narayanan Hariharan, Ada Staal, Dennis Farrelly, Michele H. French, JoAnn Swartz, Donald Egan, Effie Tozzo, Peter T. W. Cheng, Gustav E Welzel, Simeon Taylor, Rene Belder, Chen Sean, Liqun Gu
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 321(1)
There are two major defects in type 2 diabetes: 1) insulin resistance and 2) insulin deficiency due to loss of beta-cell function. Here we demonstrated that treatment with muraglitazar (a dual peroxisome proliferator-activated receptor alpha/gamma ac
Autor:
Dennis Farrelly, Narayanan Hariharan, Rajasree Golla, Lin Cheng, Jonathan Lippy, Hao Zhang, Ramakrishna Seethala, Zhengping Ma, Peter T. W. Cheng, Kevin O’Malley, Kasim A. Mookhtiar, Litao Zhang
Publikováno v:
Analytical biochemistry. 363(2)
Peroxisome proliferator-activated receptors (PPARs) and other members of the nuclear hormone receptor family are important drug targets for the treatment of metabolic diseases. PPARalpha and PPARgamma play crucial roles in lipid and glucose metabolis
Autor:
Pratik V, Devasthale, Sean, Chen, Yoon, Jeon, Fucheng, Qu, Denis E, Ryono, Wei, Wang, Hao, Zhang, Lin, Cheng, Dennis, Farrelly, Rajasree, Golla, Gary, Grover, Zhengping, Ma, Lisa, Moore, Ramakrishna, Seethala, Wei, Sun, Arthur M, Doweyko, Gamini, Chandrasena, Paul, Sleph, Narayanan, Hariharan, Peter T W, Cheng
Publikováno v:
Bioorganicmedicinal chemistry letters. 17(8)
A novel series of potent dual agonists of PPARalpha and PPARgamma, the alkoxybenzylglycines, was identified and explored using a solution-phase library approach. The synthesis and structure-activity relationships of this series of dual PPARalpha/gamm
Autor:
Karen Brown, Sergio A. Lira, Narayanan Hariharan, Jianming Ren, Kasim A. Mookhtiar, Aaron Tieman, Richard E. Gregg, Deborah Hagan, Dennis Farrelly
The importance of glucokinase (GK; EC 2.7.1.12 ) in glucose homeostasis has been demonstrated by the association of GK mutations with diabetes mellitus in humans and by alterations in glucose metabolism in transgenic and gene knockout mice. Liver GK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8ff419851905f6892e2f9c7b601e8bb
https://europepmc.org/articles/PMC24467/
https://europepmc.org/articles/PMC24467/
Autor:
Donna Hillyer, Stephen S. Kalinowski, Karen S. Brown, Narayanan Hariharan, Allison Treloar, C.M. Arbeeny, Kasim A. Mookhtiar, Dennis Farrelly, Deborah Hagan, Talal Sabrah
Publikováno v:
Diabetes. 46(1)
Glucokinase is the predominant hexokinase in pancreatic β-cells and liver parenchymal cells and functions as a critical component of the glucose-sensing apparatus in these glucose-responsive cell types. In the β-cells, the sensing leads to insulin